Live from the NIH registry
Studies recruiting near Davenport right now
Top 25 of 42 recruiting studies, sorted by proximity — each links to its official registry page
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Wake Forest University Health Sciences
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Versono Medical Ltd
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Davenport, Iowa (2.7 mi)
· Sponsor: DalCor Pharmaceuticals
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Arterial Disease of Legs, Below-the-knee Obstruction
N/A
Interventional 368 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Concept Medical Inc.
AcoArt Litos PCB Below-the-knee Global Trial
Chronic Limb-Threatening Ischemia
N/A
Interventional 288 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Acotec Scientific Co., Ltd
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: National Cancer Institute (NCI)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: SWOG Cancer Research Network
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC)
Phase 3
Interventional 1,040 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 3
Interventional 364 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pneumococcal Disease
Phase 3
Interventional 3,230 participants sought
MidValley Research, Inc — Moline, Illinois (5.8 mi)
· Sponsor: Pfizer
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Moderate Aortic Valve Stenosis
Phase 2, Phase 3
Interventional 1,276 participants sought
Cardiovascular Medicine — Moline, Illinois (5.8 mi)
· Sponsor: Kardigan, Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Amgen
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Genesis Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: Stryker Instruments
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
Mid West Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Baylor Research Institute